SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052503
Filing Date
2020-11-09
Accepted
2020-11-09 16:11:47
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20200930.htm   iXBRL 10-Q 2687783
2 EX-10.1 atra-ex101_113.htm EX-10.1 463186
3 EX-10.2 atra-ex102_111.htm EX-10.2 319675
4 EX-10.3 atra-ex103_87.htm EX-10.3 162935
5 EX-10.4 atra-ex104_206.htm EX-10.4 62406
6 EX-31.1 atra-ex311_6.htm EX-31.1 16112
7 EX-31.2 atra-ex312_8.htm EX-31.2 16145
8 EX-32.1 atra-ex321_7.htm EX-32.1 8038
  Complete submission text file 0001564590-20-052503.txt   8665706

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA atra-20200930.xsd EX-101.SCH 43251
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20200930_cal.xml EX-101.CAL 44326
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20200930_def.xml EX-101.DEF 130593
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20200930_lab.xml EX-101.LAB 355113
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20200930_pre.xml EX-101.PRE 250079
14 EXTRACTED XBRL INSTANCE DOCUMENT atra-10q_20200930_htm.xml XML 1246140
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 201297801
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences